←
Mat Legut, PhD149 posts
Mat Legut, PhD avatar

Mat Legut, PhD

@MatLegut

Unconventional T cell biologist and genome engineer. Previously @cardiffuni @nyuniversity @nygenome 🏳️‍🌈

◷ Joined September 2020▧ 27 Photos and videos
Mat Legut, PhD avatar
Mat Legut, PhD@MatLegut·6 May 2024

After some time in the making, I am really happy to announce @OverT_Bio’s official launch today. I am excited and humbled by the experience of building OverT with a terrific team of scientists and operators #startup #celltherapy #cancer

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debuts-…

OverT Bio avatar
⟳ Mat Legut, PhD retweeted
OverT Bio@OverT_Bio·Mar 23

Excited to share a big milestone for OverT Bio—we’ve formed our Clinical Advisory Board. Grateful to partner with an incredible group of leaders as we build scalable γδ CAR-T therapies for solid tumors. businesswire.com/news/home/2…

Júlia Domingo avatar
⟳ Mat Legut, PhD retweeted
Júlia Domingo@JuliaDiumenge·17 Jun 2024

Come and join the extraordinary team of ALLOX and help us accelerate the discovery of more effective therapies! 👉allox.bio/careers

ALLOX@ALLOXbio17 Jun 2024

Our team in #Barcelona is expanding & we're #hiring 2 talented scientists to fill these exciting new positions: a Lead Scientist & a Research Associate. Do u want to make a real difference in the future of applied high-throughput genetics and therapeutics? #PhdChat #ScienceJobs

Post attachment
Cancer Research Institute avatar
⟳ Mat Legut, PhD retweeted
Cancer Research Institute@CancerResearch·7 May 2024

🎉Congratulations to the team at @OverT_Bio and its co-founders, @MatLegut and former CRI Tech Impact Award Grantee @nevillesanjana on the company's debut! Learn more in @endpts:

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debuts-…

Neville Sanjana avatar
⟳ Mat Legut, PhD retweeted
Neville Sanjana@nevillesanjana·6 May 2024

Congrats to @MatLegut & the entire @OverT_Bio team! Grateful for the opportunity to translate discoveries from our lab @nygenome & @nyuniversity into therapies for cancer patients. Thrilled to be a part of this amazing team — onward and upward! 🚀

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debuts-…

Mat Legut, PhD avatar
Mat Legut, PhD@MatLegut·6 May 2024

Last but not least, special mention to our first investors who supported us from the very start of this journey: Jim Magid, Dr. Anthony Evnin and Jeanette Cone Kimmel

OverT Bio avatar
⟳ Mat Legut, PhD retweeted
OverT Bio@OverT_Bio·6 May 2024

We're thrilled to launch OverT Bio! Debuting with $16M of initial financing, we will develop safe and effective #celltherapies for solid tumor cancers. endpts.com/overt-bio-debuts-…

T-cell Modulation Group avatar
⟳ Mat Legut, PhD retweeted
T-cell Modulation Group@TcellResearch·24 Jul 2023

Great effort from the team on this study published in Cell today! Hard work pays off - well done everyone 👏🏻 Exciting science - discovering new T-cell receptors for cancer immunotherapies 🔬 #cancerimmunotherpies #cellscience #tcells cell.com/cell/fulltext/S0092…

T-cell Modulation Group avatar
⟳ Mat Legut, PhD retweeted
T-cell Modulation Group@TcellResearch·7 Jun 2023

For anyone interested in our work and our team - we would greatly appreciate extra votes in the following competition! Voting is open until the 4th July 🗳️🙏🏻🧬🧪 MolecularCloud | 2023 Distinguished Research Awards for Gene and Cell Therapy molecularcloud.org/researcha…